LSVVX | VIVAX | LSVVX / VIVAX | |
Total Expense Ratio | 0.35 | 0.17 | 206% |
Annual Report Gross Expense Ratio | 0.56 | 0.17 | 329% |
Fund Existence | 18 years | 32 years | - |
Gain YTD | -3.202 | -3.426 | 93% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 3000 | 3,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 122M | 191B | 0% |
Annual Yield % from dividends | 2.14 | 2.14 | 100% |
Returns for 1 year | -7.15 | 3.39 | -211% |
Returns for 3 years | 3.05 | 12.71 | 24% |
Returns for 5 years | 65.99 | 69.89 | 94% |
Returns for 10 years | 49.10 | 92.45 | 53% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XNTK | 192.21 | 6.87 | +3.70% |
SPDR® NYSE Technology ETF | |||
BBP | 56.91 | 0.94 | +1.68% |
Virtus LifeSci Biotech Products ETF | |||
VPL | 74.72 | 0.89 | +1.21% |
Vanguard FTSE Pacific ETF | |||
SPVU | 49.28 | 0.43 | +0.88% |
Invesco S&P 500® Enhanced Value ETF | |||
RWX | 25.71 | -0.33 | -1.27% |
SPDR® Dow Jones® International RelEstETF |